Directory51.com
Categories:
Browse Categories:
Aerospace & Defense
Agriculture
Automative & Transport
Business Services
Computers & Software
Education
Electronics
Energy & Environment
Financial Services
Food & Beverage
Health Care
Manufacturing
Media & Entertainment
Organizations & Institutions
Pharmaceuticals
Real Estate & Construction
Retail & Consumer Services
Wholesale Trade
North America
change location
Search
Apotex Fermentation Inc.
Address:
50 Scurfield Blvd.
Winnipeg, MB R3Y 1G4 CA
Phone:
(204) 989-6830
Fax:
(204) 989-9160
Mailing Address:
50 Scurfield Blvd.
Winnipeg, MB R3Y 1G4 CA
Legal Name:
Apotex Fermentation Inc.
Year Established:
1991
Website:
http://www.apoferm.mb.ca
Company Information
Listed in:
Pharmaceutical & Medicine Manufacturing
Description:
Apotex Fermentation Inc. is part of the Apotex Group of Companies, the largest Canadian-owned pharmaceutical group. The purpose of AFI is to discover and develop fermentation-based technologies for the production of Active Pharmaceutical Ingredients (APIs) and to manufacture APIs for eventual sale as final dosage forms in Canada and internationally. AFI is an advanced technology company utilizing state-of-the-art techniques for search and discovery, strain selection and improvement and bioprocess scale-up. AFI staff is highly qualified and trained in sophisticated chemical biological and pharmaceutical technologies. Our multimillion dollar facility in Southwest Winnipeg is the largest fermentation-based GMP facility in Canada.
Map
Products
Lovastatin
Cyclosporin
Bulk pharmaceutical product Cyclosporin USP
Pravastatin
Bulk pharmaceutical product Pravastatin USP
Contract Manufacturing
Contract manufacturing of active pharmaceutical ingredients using fermentation based technologies under GMP
Services
Research And Development
Research and Development of fermentation based technologies in the pharmaceutical industry
Process Development
Development of microbiological and chemical processes for the production of active pharmaceutical ingredients
Scale Up
Scale up of lab scale microbiological and chemical processes to commercial production scale processes for the manufacture of active pharmaceutical